SCHEMBL6510152

SCHEMBL6510152

Nc1ccccc1NCc1ccc2oc(C(=O)NO)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 4/20 0.52
HDAC1 Q13547 8/20 0.45
HDAC3 O15379 2/20 0.45
HDAC8 Q9BY41 1/20 0.45
HPGD P15428 3/20 0.43
TP53 P04637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6506293 0.84 HDAC1 (0.58) HDAC1HDAC8HPGDTP53ALDH1A1
SCHEMBL211452 0.81 HDAC2 (0.53) HDAC2HDAC1HDAC3HPGDTP53
SCHEMBL6507649 0.80 HDAC1 (0.46) HDAC1HDAC8HPGDTP53ALDH1A1
SCHEMBL6513780 0.77 FFAR1 (0.52) HDAC1HDAC8TP53SMN1; SMN2HDAC6
SCHEMBL6513479 0.76 ALDH1A1 (0.54) HDAC2HDAC1HDAC3HDAC8HPGD
SCHEMBL6512229 0.76 TP53 (0.40) HDAC2HDAC1HDAC3HDAC8HPGD
SCHEMBL1065598 0.75 HDAC1 (0.71) HDAC2HDAC1TP53SMN1; SMN2RAB9A
SCHEMBL212351 0.75 HDAC1 (0.71) HDAC2HDAC1SMN1; SMN2RAB9ANPC1
SCHEMBL6514847 0.75 TP53 (0.40) HDAC2HDAC1HDAC3HDAC8HPGD
SCHEMBL6512208 0.74 MAOA (0.49) TP53ALDH1A1RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 HDAC2 6/4885HDAC1 1/4885HDAC3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.